178 related articles for article (PubMed ID: 15675505)
1. HIV and children: the developing immune system fights back.
Feeney ME
West Indian Med J; 2004 Oct; 53(5):359-62. PubMed ID: 15675505
[TBL] [Abstract][Full Text] [Related]
2. Detection of HIV-specific cell-mediated cytotoxicity in the peripheral blood from infected children.
Buseyne F; Blanche S; Schmitt D; Griscelli C; Rivière Y
J Immunol; 1993 Apr; 150(8 Pt 1):3569-81. PubMed ID: 8096852
[TBL] [Abstract][Full Text] [Related]
3. The value of preserving HIV-specific immune responses.
Kaufmann DE; Rosenberg ES
J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
[TBL] [Abstract][Full Text] [Related]
4. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.
Betts MR; Gray CM; Cox JH; Ferrari G
Expert Rev Vaccines; 2006 Aug; 5(4):505-16. PubMed ID: 16989631
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
6. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
7. Early therapy in HIV-1-infected children: effect on HIV-1 dynamics and HIV-1-specific immune response.
Zanchetta M; Anselmi A; Vendrame D; Rampon O; Giaquinto C; Mazza A; Accapezzato D; Barnaba V; De Rossi A
Antivir Ther; 2008; 13(1):47-55. PubMed ID: 18389898
[TBL] [Abstract][Full Text] [Related]
8. Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure.
Correa R; Harari A; Vallelian F; Resino S; Munoz-Fernandez MA; Pantaleo G
AIDS; 2007 Jan; 21(1):23-30. PubMed ID: 17148964
[TBL] [Abstract][Full Text] [Related]
9. [HIV-1 nef specific cytotoxic T lymphocyte responses in long-term nonprogressors and AIDS patients].
Zhang HW; Qiu ZF; Li TS
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1973-6. PubMed ID: 15730808
[TBL] [Abstract][Full Text] [Related]
10. Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors.
Schindler M; Wildum S; Casartelli N; Doria M; Kirchhoff F
AIDS; 2007 May; 21(9):1103-7. PubMed ID: 17502720
[TBL] [Abstract][Full Text] [Related]
11. Profile of T cell immune responses in HIV-infected children from Uganda.
Ssewanyana I; Elrefaei M; Dorsey G; Ruel T; Jones NG; Gasasira A; Kamya M; Nakiwala J; Achan J; Charlebois E; Havlir D; Cao H
J Infect Dis; 2007 Dec; 196(11):1667-70. PubMed ID: 18008251
[TBL] [Abstract][Full Text] [Related]
12. Mucosal immune dysfunction in AIDS pathogenesis.
Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
[TBL] [Abstract][Full Text] [Related]
14. Effects of vitamins, including vitamin A, on HIV/AIDS patients.
Mehta S; Fawzi W
Vitam Horm; 2007; 75():355-83. PubMed ID: 17368322
[TBL] [Abstract][Full Text] [Related]
15. T lymphocyte responses in HIV-1 infection: implications for vaccine development.
Brander C; Walker BD
Curr Opin Immunol; 1999 Aug; 11(4):451-9. PubMed ID: 10448136
[TBL] [Abstract][Full Text] [Related]
16. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
[TBL] [Abstract][Full Text] [Related]
18. Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy.
Paul ME; Mao C; Charurat M; Serchuck L; Foca M; Hayani K; Handelsman EL; Diaz C; McIntosh K; Shearer WT;
J Allergy Clin Immunol; 2005 Apr; 115(4):848-55. PubMed ID: 15806009
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of immune escape in HIV infection.
Wodarz D; Nowak MA
Wien Klin Wochenschr; 1999 Jun; 111(11):419-27. PubMed ID: 10420492
[TBL] [Abstract][Full Text] [Related]
20. Anti-HIV adaptive immunity: determinants for viral persistence.
Yamamoto H; Matano T
Rev Med Virol; 2008; 18(5):293-303. PubMed ID: 18416450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
